Table 1:

Patient-derived cell lines, organoids, and xenografts are important tools to model patient tumor behaviors.

	Patient Derived Cell Lines	Patient Derived Organoids (PDOs)	Patient Derived Xenografts (PDXs)
Development Time	1 week	4-6 weeks	6-8 months
Initiation Success	Minimal	Moderate	Moderate
Cost	$	$$	$$$$
Throughput	High	Moderate	Low
Standardization	High	Low	Moderate